×
-0.00125142207053472 -0.00299927603681869 0.000103423311614381 0.00217188954390328 -0.0143758403144068 -0.0267866377081394 -0.0174785396628401 -0.0505739993794602
Stockreport

Fate Therapeutics adds to up move, shares ahead 16% [Seeking Alpha]

FATE THERAPEUTICS (FATE)  More Company Research Source: Seeking Alpha
Last fate therapeutics earnings: 11/1 04:01 pm Check Earnings Report
PDF Fate Therapeutics adds to up move, shares ahead 16%Fate Therapeutics (FATE+15.8%) is up again on double normal volume. Shares have rallied111% since mid-December.Last month, the company reported positive preliminary results from a Phase 1/2 clinical trial assessing programmed cellular immunotherapyProTmune in blood cancer patients.Its lead I-O candidate is Phase 1-stageFate-NK100, a donor-derived adaptive memory natural killer cell therapy.Previously:Fate Therapeutics' ProTmune shows positive effect in early-stage study; shares up 5% (Dec. 12, 2017)See all stocks on the move »Now read:Financial Exchange Stock Talk: Bhavneesh Sharma On scPharmaceuticals » [Read more]

IMPACT SNAPSHOT EVENT TIME: FATE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS